文献速递糖尿病

2型糖尿病的代谢谱及其与肾脏并发症的关联

Metabolic Profiles of Type 2 Diabetes and Their Association With Renal Complications.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

研究基于3556例医院来源的2型糖尿病 derivation 队列和931例社区调查的外部验证队列,用代谢综合征5个组分聚类识别6种代谢谱。严重高血糖谱与中度血脂异常谱与糖尿病肾脏病风险升高相关,并在验证队列中复现。

要点

  • 共识别6种代谢谱,严重高血糖谱与中度血脂异常谱为糖尿病肾脏病风险标志。
  • 推导队列中严重高血糖谱的DKD风险HR为1.72(95%CI 1.39-2.12)。
  • 验证队列中严重高血糖谱与中度血脂异常谱的DKD调整OR分别为1.24和1.39。

核心结论

  • 在2型糖尿病患者中识别出6种常见代谢谱,严重高血糖和中度血脂异常被验证为糖尿病肾脏病的显著风险标志。

研究设计与样本

  • 研究纳入3556例来自医院的2型糖尿病参与者作为推导队列,以及931例来自社区调查的2型糖尿病参与者作为外部验证队列。
  • 在推导队列中使用代谢综合征的5个组分进行聚类分析,并评估各聚类与结局的关系;在验证队列中将参与者分配至各聚类以验证发现。

主要发现

  • 推导队列识别出6种代谢谱聚类。
  • 与聚类1相比,聚类3(严重高血糖)的DKD风险HR为1.72(95%CI 1.39-2.12),大量白蛋白尿风险HR为2.74(95%CI 1.84-4.08),终末期肾病风险HR为4.31(95%CI 1.16-15.99),eGFR下降风险P<.001。
  • 与聚类1相比,聚类4(中度血脂异常)的DKD风险HR为1.97(95%CI 1.53-2.54),大量白蛋白尿风险HR为2.62(95%CI 1.61-4.25)。
  • 在验证队列中,聚类3和聚类4的DKD风险显著升高,调整OR分别为1.24(95%CI 1.07-1.44)和1.39(95%CI 1.03-1.87)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The components of metabolic syndrome (MetS) are interrelated and associated with renal complications in patients with type 2 diabetes (T2D). OBJECTIVE: We aimed to reveal prevalent metabolic profiles in patients with T2D and identify which metabolic profiles were risk markers for renal progression. METHODS: A total of 3556 participants with T2D from a hospital (derivation cohort) and 931 participants with T2D from a community survey (external validation cohort) were included. The primary outcome was the onset of diabetic kidney disease (DKD), and secondary outcomes included estimated glomerular filtration rate (eGFR) decline, macroalbuminuria, and end-stage renal disease (ESRD). In the derivation cohort, clusters were identified using the 5 components of MetS, and their relationships with the outcomes were assessed. To validate the findings, participants in the validation cohort were assigned to clusters. Multivariate odds ratios (ORs) of the primary outcome were evaluated in both cohorts, adjusted for multiple covariates at baseline. RESULTS: In the derivation cohort, 6 clusters were identified as metabolic profiles. Compared with cluster 1, cluster 3 (severe hyperglycemia) had increased risks of DKD (hazard ratio [HR] [95% CI]: 1.72 [1.39-2.12]), macroalbuminuria (2.74 [1.84-4.08]), ESRD (4.31 [1.16-15.99]), and eGFR decline [P < .001]; cluster 4 (moderate dyslipidemia) had increased risks of DKD (1.97 [1.53-2.54]) and macroalbuminuria (2.62 [1.61-4.25]). In the validation cohort, clusters 3 and 4 were replicated to have significantly increased risks of DKD (adjusted ORs: 1.24 [1.07-1.44] and 1.39 [1.03-1.87]). CONCLUSION: We identified 6 prevalent metabolic profiles in patients with T2D. Severe hyperglycemia and moderate dyslipidemia were validated as significant risk markers for DKD.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Li S, Cui M, Liu Y, et al. Metabolic Profiles of Type 2 Diabetes and Their Association With Renal Complications. J Clin Endocrinol Metab. 2024. PMID: 37933705. doi:10.1210/clinem/dgad643

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。